BHRB
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 13.14K | $906,369 | n/a | n/a |
| Q2 2026 | 77 | +9 | 6.28M | $448.26M | +15 | −6 |
| Q1 2026 | 71 | +8 | 4.63M | $288.46M | +10 | −2 |
| Q4 2025 | 63 | 0 | 4.58M | $285.68M | +1 | −1 |
| Q3 2025 | 15 | 0 | 2.98M | $183.80M | +1 | −1 |
| Q2 2025 | 12 | +1 | 2.64M | $157.68M | +2 | −1 |
| Q1 2025 | 8 | +1 | 816.76K | $45.83M | +1 | n/a |
| Q4 2024 | 7 | 0 | 680.95K | $42.47M | n/a | n/a |
| Q3 2024 | 6 | -1 | 361.88K | $22.08M | +1 | −2 |
| Q2 2024 | 7 | n/a | 394.62K | $20.12M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 291.15K | n/a | $14.85M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Renaissance Technologies ✦ | 55.46K | n/a | $2.83M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 17.76K | n/a | $905,558 | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 9.63K | n/a | $491,090 | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 8.38K | n/a | $427,417 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 8.09K | n/a | $412,428 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 4.14K | n/a | $211,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 161 holders, 6.73M shares, $413.01M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 35 sh @ 70.57 · $2,470
Director · 1.20K sh @ 73.67 · $88,398
Open-market sales (S)
Director · 263 sh · $19,175
Director · 2.89K sh · $210,231
Director · 1.50K sh · $109,538
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology